Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxia-inducible gene RTP801 (RTP801)
- Target
- RTP801
- Molecular classification
- Stress-response protein
01
Overview
Hypoxia-inducible gene RTP801 encodes a highly conserved stress-response protein that integrates environmental cues like hypoxia into intracellular decisions about growth arrest versus survival/apoptosis mainly through negative regulation of the mTOR/Akt axis. Its function varies with cellular context—from protective antioxidant effects during acute proliferation-associated stresses to pro-apoptotic actions driving pathology when chronically elevated post-differentiation or under persistent insult.
- Other names
- REDD1Regulated in Development and DNA Damage Responses 1DDIT4DNA-damage-inducible transcript 4Dig2
02
Mechanism of action
Inhibits mTOR signaling by activating TSC2, negatively regulates Akt signaling.
03
Biological functions
Negative regulation of mTOR signalingRegulation of Akt kinase activityStress responseApoptosis modulationCell growth regulationDifferentiation
04
Disease associations
NeurodegenerationPulmonary injuryEmphysemaCancerLeukemia
05
Safety considerations
Context-dependent effects (pro-apoptotic vs. anti-apoptotic)Potential for off-target effects due to involvement in multiple signaling pathways
06
Interacting drugs
ATRA (all-trans retinoic acid)
Beyond the preview
Go deeper on Hypoxia-inducible gene RTP801 (RTP801).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hypoxia-inducible gene RTP801 (RTP801).